FI925531A0 - Process foer framstaellning av poroesa cellulosamatriser - Google Patents

Process foer framstaellning av poroesa cellulosamatriser

Info

Publication number
FI925531A0
FI925531A0 FI925531A FI925531A FI925531A0 FI 925531 A0 FI925531 A0 FI 925531A0 FI 925531 A FI925531 A FI 925531A FI 925531 A FI925531 A FI 925531A FI 925531 A0 FI925531 A0 FI 925531A0
Authority
FI
Finland
Prior art keywords
matrices
pct
cellulose
sec
manufacture
Prior art date
Application number
FI925531A
Other languages
English (en)
Other versions
FI101195B1 (fi
FI925531A (fi
FI101195B (fi
Inventor
Bo Ragnar Ek
Kjell Gunnar Eriksson
Per Gustaf Haokan Nyqvist
Gert Anders Narsson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of FI925531A0 publication Critical patent/FI925531A0/fi
Publication of FI925531A publication Critical patent/FI925531A/fi
Application granted granted Critical
Publication of FI101195B1 publication Critical patent/FI101195B1/fi
Publication of FI101195B publication Critical patent/FI101195B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2201/00—Foams characterised by the foaming process
    • C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/044—Elimination of an inorganic solid phase
    • C08J2201/0444—Salts
    • C08J2201/0446—Elimination of NaCl only
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Amplifiers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI925531A 1990-06-06 1992-12-04 Prosessi huokoisten selluloosamatriisien valmistamiseksi FI101195B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002017A SE9002017D0 (sv) 1990-06-06 1990-06-06 Process for manufacture of matrices
PCT/SE1991/000396 WO1991018590A1 (en) 1990-06-06 1991-06-05 Process for the manufacture of porous cellulose matrices

Publications (4)

Publication Number Publication Date
FI925531A0 true FI925531A0 (fi) 1992-12-04
FI925531A FI925531A (fi) 1992-12-04
FI101195B1 FI101195B1 (fi) 1998-05-15
FI101195B FI101195B (fi) 1998-05-15

Family

ID=20379691

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925531A FI101195B (fi) 1990-06-06 1992-12-04 Prosessi huokoisten selluloosamatriisien valmistamiseksi

Country Status (14)

Country Link
US (1) US5607695A (fi)
EP (1) EP0532611B1 (fi)
JP (1) JPH05507696A (fi)
AT (1) ATE136213T1 (fi)
AU (1) AU644887B2 (fi)
CA (1) CA2084680C (fi)
DE (1) DE69118533T2 (fi)
DK (1) DK0532611T3 (fi)
ES (1) ES2086542T3 (fi)
FI (1) FI101195B (fi)
GR (1) GR3020047T3 (fi)
NO (1) NO304726B1 (fi)
SE (1) SE9002017D0 (fi)
WO (1) WO1991018590A1 (fi)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702160B1 (fr) * 1993-03-02 1995-06-02 Biovecteurs As Vecteurs particulaires synthétiques et procédé de préparation.
SE9301220D0 (sv) * 1993-04-14 1993-04-14 Kabi Pharmacia Ab Manufacturing matrices
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
CA2271652A1 (en) * 1996-11-12 1998-05-22 Pharmacia & Upjohn Ab Compact member comprising a plurality of porous cellulose matrices, (pcms), method of manufacturing and use thereof
SE9604124D0 (sv) 1996-11-12 1996-11-12 Pharmacia & Upjohn Ab Compact member, method of manufacturing and use thereof
DE69835275T2 (de) 1997-01-07 2007-07-19 Kaneka Corp. Absorbens zum reinigen von körperflüssigkeiten
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
DE19745629A1 (de) * 1997-10-16 1999-04-22 Cff Cellulose Fuellstoff Fabri Verfahren zur Herstellung eines aus zerkleinerten Pflanzenfasern bestehenden Ballast- oder Füllstoffes und seine Verwendung
EP0966486B1 (de) * 1997-12-14 2005-04-13 THÜRINGISCHES INSTITUT FÜR TEXTIL- UND KUNSTSTOFF-FORSCHUNG e.V. Verfahren zur herstellung von regulären porösen perlcellulosen
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
ES2197600T3 (es) 1999-01-29 2004-01-01 Disphar International B.V. Composiciones farmaceuticas.
US6610317B2 (en) 1999-05-27 2003-08-26 Acusphere, Inc. Porous paclitaxel matrices and methods of manufacture thereof
AU763041B2 (en) * 1999-08-25 2003-07-10 Alkermes, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
MXPA02004650A (es) * 1999-11-12 2002-09-02 Scherer Technologies Inc R P Granulos amortiguadores de celulosa microcristalina.
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US20030125236A1 (en) * 2000-12-29 2003-07-03 Advenced Inhalation Research, Inc. Particles for inhalation having rapid release properties
EP1345629A2 (en) 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
WO2003043603A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
ES2415654T3 (es) * 2001-11-20 2013-07-26 Civitas Therapeutics, Inc. Composiciones particuladas mejoradas para suministro pulmonar
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
TW200507882A (en) * 2003-07-17 2005-03-01 Kyowa Hakko Kogyo Kk Solid formulations
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
JP4969104B2 (ja) * 2004-01-30 2012-07-04 旭化成ケミカルズ株式会社 多孔質セルロース凝集体及びその成型体組成物
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
NO20065147L (no) * 2006-11-08 2008-05-09 Ntnu Tech Transfer As Nanokompositter basert på cellulosewhiskers og celluloseplast
FR2945945B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
KR101331481B1 (ko) * 2011-10-13 2013-11-20 도쿠슈 도카이 세이시 가부시키가이샤 전기 화학 소자용 세퍼레이터 및 그 제조 방법
WO2013054884A1 (ja) * 2011-10-13 2013-04-18 特種東海製紙株式会社 微多孔膜及びその製造方法
CN103329310B (zh) 2011-10-13 2016-09-21 特种东海制纸株式会社 微多孔膜及其制造方法
RU2013134483A (ru) * 2011-10-13 2015-01-27 Токусю Токай Пейпер Ко., Лтд. Пористая мембрана и способ ее получения
CN111116761B (zh) * 2019-11-13 2022-02-18 王卫 改性微晶纤维素的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286829A (fi) * 1961-12-29
CS172640B1 (fi) * 1974-05-30 1977-01-28
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
SE434848B (sv) * 1976-04-22 1984-08-20 Purdue Research Foundation Forfaringssett for framstellning av porosa cellulosaperlor
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4269859A (en) * 1979-04-19 1981-05-26 Brown Company Cellulose floc granules and process
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JPS6443530A (en) * 1987-08-10 1989-02-15 Asahi Chemical Ind Porous cellulose particle and its production
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates

Also Published As

Publication number Publication date
SE9002017D0 (sv) 1990-06-06
CA2084680A1 (en) 1991-12-07
US5607695A (en) 1997-03-04
AU7994091A (en) 1991-12-31
CA2084680C (en) 2001-10-02
GR3020047T3 (en) 1996-08-31
JPH05507696A (ja) 1993-11-04
NO924671L (no) 1992-12-03
NO304726B1 (no) 1999-02-08
AU644887B2 (en) 1993-12-23
FI101195B1 (fi) 1998-05-15
FI925531A (fi) 1992-12-04
DE69118533T2 (de) 1996-09-12
EP0532611A1 (en) 1993-03-24
FI101195B (fi) 1998-05-15
DK0532611T3 (da) 1996-08-05
EP0532611B1 (en) 1996-04-03
NO924671D0 (no) 1992-12-03
ES2086542T3 (es) 1996-07-01
WO1991018590A1 (en) 1991-12-12
ATE136213T1 (de) 1996-04-15
DE69118533D1 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
FI925531A (fi) Process foer framstaellning av poroesa cellulosamatriser
ES8300137A1 (es) Un procedimiento para la preparacion de almidones tratados
GR3020008T3 (en) Process for preparing mechanically stable, well disintegrating tablets from small active agent containing solid forms
DE3170764D1 (en) Fast disaggregating pharmaceutical tablet
MY104010A (en) Pharmaceutical compositions.
JPS5759803A (en) Granule of l-sodium ascorbate, its preparation, and tablet comprising it
RU98104417A (ru) Комбинированные осмотические и объем-образующие слабительные средства
DE60212464D1 (de) Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
ES8500760A1 (es) Procedimiento de obtencion de un granulado adecuado para la fabricacion de tabletas.
FI954883A0 (fi) Matriisien valmistus
GR3003872T3 (fi)
ATE181833T1 (de) Wasserdispergierbare tablette enthaltend lamotrigin

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN AKTIEBOLAG

HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN AKTIEBOLAG

MA Patent expired